Vanda's NDA Rejection Challenge Can't Be Heard At DC Court
By Gina Kim · July 20, 2026, 5:45 PM EDT
A D.C. federal judge has said he no longer has jurisdiction to hear Vanda Pharmaceuticals Inc.'s challenge alleging the FDA violated the Appointments Clause by allowing a non-officer to exercise "signatory...
To view the full article, register now.